Heterogeneous expression of ACE2 and TMPRRS2 in mesenchymal stromal cells

Journal of Cellular and Molecular Medicine

Paolo Cinelli¹  Debora Wanner²  Melanie Generali²  Debora Kehl²  Simon P. Hoerstrup³  Michal J. Okoniewski⁴ 

[1] Center for Applied Biotechnology and Molecular Medicine (CABMM), University of Zurich, Zurich, Switzerland;Department of Trauma Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland;Institute for Regenerative Medicine (IREM), Center for Therapy Development and Good Manufacturing Practice, University of Zurich, Zurich, Switzerland;Institute for Regenerative Medicine (IREM), Center for Therapy Development and Good Manufacturing Practice, University of Zurich, Zurich, Switzerland;Center for Applied Biotechnology and Molecular Medicine (CABMM), University of Zurich, Zurich, Switzerland;Wyss Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland;Scientific IT Services ETH Zurich, ETH Zurich, Zürich, Switzerland;

关键词: adult stem cells;    cellular therapy;    mesenchymal stromal cells (MSCs);    sars‐CoV‐2;   

DOI  :  10.1111/jcmm.17048

来源: Wiley

【 授权许可】

CC BY